Follow DRNO on...
US-based pharma researcher Decision Resources Group (DRG) has expanded to the Asia Pacific (APAC) region, with the establishment of a consulting office in Singapore. More
US-based pharma research firm Decision Resources Group (DRG) has launched an app called the 'Ask DRG Insights Platform', giving clients healthcare market data on a modular basis. More
Pharma researcher Decision Resources Group (DRG) has formed an alliance with Latin American prescription audits specialist Close-Up International (CUI), through which it will offer its insights and data products to clients across the region. More
In the US, pharma researcher Decision Resources Group (DRG) has acquired health plan data specialist Adaptive Software. Terms of the deal were not disclosed. More
In the US, pharma researcher Decision Resources Group (DRG) has unified its portfolio of companies under the DRG brand name. More
In the US, pharma researcher Decision Resources Group (DRG) has acquired membership-based hospital research specialist Healthcare Business Insights (HBI). Terms of the deal were not disclosed. More
US-based pharma researcher Decision Resources Group (DRG) has appointed Mark Luck Olson as President, Global Consulting Services. More
US-based pharma researcher Decision Resources Group (DRG) has enhanced its Marketrack medical technology tracker with purchase order data and pricing analysis, delivered through an interactive dashboard. More
In the US, pharma researcher Decision Resources Group (DRG) has acquired Cambridge, Mass-based life sciences data analytics and business intelligence company Relay Technology Management. Terms were not disclosed. More
US-based Decision Resources Group has made its first overseas purchase, acquiring UK health economics consultant Abacus International. Terms were not disclosed. More
Mumbai, India-based pharmaceutical product manufacturer Piramal Healthcare is to acquire US-based pharma research firm Decision Resources Group (DRG) for around $635m. More
In the US, Decision Resources has acquired consulting and MR firm PharmaStrat, a specialist in reimbursement and organized customer segments for biopharma manufacturers; and has also announced a change of name. More
US pharma and healthcare specialist Decision Resources has relocated its headquarters from Waltham to Burlington, Massachusetts, in preparation for future growth. More
US pharma and healthcare specialist Decision Resources has launched an interactive web-based platform that allows users to search for 'product analogues' - modified drugs based on the structure of existing medicine - and assess potential market opportunities. More
US pharmaceutical and health care specialist Decision Resources has acquired BioTrends Research Group, which provides syndicated and custom market research services to mid-size pharma markets. Terms were not disclosed. More
US pharma and healthcare research firm Decision Resources has restructured into two segments - Biopharma and Medical Technology - and made a number of promotions accordingly. More
US-based healthcare market research provider Decision Resources is expanding its Physician and Payer Forum product line to include primary research on European attitudes towards cancer drugs on the market. More
In the US, healthcare market research firm Decision Resources has acquired physician and consumer opinions agency Manhattan Research. Terms of the deal were not disclosed. More
US-based healthcare specialist Decision Resources, Inc. has boosted its managed care franchise with the acquisition of Fingertip Formulary, which provides access to and insight into formulary data in the United States. More
Pharmaceutical and healthcare insight firm Decision Resources, Inc. has acquired Arlington Medical Resources, Inc. (AMR), a provider of market intelligence for the pharma and diagnostic imaging industries. More
In the US, pharma research firm Decision Resources has announced plans to acquire the Life Sciences business of Wood Mackenzie, which comprises market research, data and analysis on the biopharmaceutical and animal health industries. Terms of the deal were not disclosed. More
US pharma research firm Decision Resources has followed up its recent cash injection with the appointment of former Thomson Healthcare Executive VP Shahir Kassam-Adams as Chief Strategy Officer, charged with managing its acquisition plans. More
Pharma research firm Decision Resources has announced that Providence Equity Partners has acquired majority control in the company. The firm says it will use the cash to fund its growth. More
US agencies Decision Resources and PharMetrics are to work together on a new interactive product, DecisionMETRICS(TM), to enhance the way pharmaceutical companies analyze their disease markets. More
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online
